Quality of life more than 10 years after radiotherapy for localized prostate cancer-impact of time after treatment and prescription dose
- PMID: 33034812
- PMCID: PMC7886756
- DOI: 10.1007/s11136-020-02639-7
Quality of life more than 10 years after radiotherapy for localized prostate cancer-impact of time after treatment and prescription dose
Abstract
Purpose: Analysis of quality of life changes after radiotherapy with focus on the impact of time after treatment and prescription dose.
Methods: Consecutive patients were treated with doses from 70.2/1.8 Gy (n = 206) to 72/1.8-2.0 Gy (n = 176) in a single centre and surveyed using the Expanded Prostate Cancer Index Composite questionnaire.
Results: Urinary and bowel bother scores decreased 1 / 3 / 6 points and 7 / 7 / 9 points on average 1 / 5 / 10 years after RT in comparison to baseline scores. The rate of urinary (need of pads in 8% vs. 15% before vs. 10 years after RT; p = 0.01) and bowel (uncontrolled leakage of stool in 5% vs. 12% before vs. 10 years after RT; p < 0.01) incontinence, as well as rectal bleeding (4% vs. 8% before vs. 10 years after RT; p = 0.05) increased. Sexual function scores decreased (erections sufficient for intercourse in 36% vs. 12% before vs. 10 years after RT; p < 0.01). A higher dose had a statistically significant impact on urinary bother and stool incontinence, but also tended to decrease urinary continence. Age and comorbidities did not have an influence on score changes, but on baseline urinary function/bother and baseline sexual function.
Conclusion: Apart from an increasing rate of erectile dysfunction, urinary and bowel incontinence rates increased with increasing follow-up period. A higher dose was found to be associated with increased urinary problems and larger stool incontinence rates. Age and comorbidities were found to be relevant for baseline scores, but not for score changes.
Keywords: Conformal radiotherapy; Dose–response relationship; Prostate neoplasms; Quality of life.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Similar articles
-
Quality of Life Changes >10 Years After Postoperative Radiation Therapy After Radical Prostatectomy for Prostate Cancer.Int J Radiat Oncol Biol Phys. 2019 Oct 1;105(2):382-388. doi: 10.1016/j.ijrobp.2019.06.004. Epub 2019 Jun 12. Int J Radiat Oncol Biol Phys. 2019. PMID: 31201895
-
Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population.Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):51-9. doi: 10.1016/s0360-3016(00)01365-1. Int J Radiat Oncol Biol Phys. 2001. PMID: 11163497 Review.
-
Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment.BMC Cancer. 2009 Aug 24;9:296. doi: 10.1186/1471-2407-9-296. BMC Cancer. 2009. PMID: 19703300 Free PMC article.
-
Health-related quality of life after adjuvant and salvage postoperative radiotherapy for prostate cancer - a prospective analysis.Radiother Oncol. 2008 Jul;88(1):135-9. doi: 10.1016/j.radonc.2007.10.022. Epub 2007 Nov 19. Radiother Oncol. 2008. PMID: 18022263
-
Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature.Eur Urol. 2012 Jan;61(1):112-27. doi: 10.1016/j.eururo.2011.09.027. Epub 2011 Oct 6. Eur Urol. 2012. PMID: 22001105 Review.
Cited by
-
Management of Medium and Long Term Complications Following Prostate Cancer Treatment Resulting in Urinary Diversion - A Narrative Review.Front Surg. 2021 Aug 9;8:688394. doi: 10.3389/fsurg.2021.688394. eCollection 2021. Front Surg. 2021. PMID: 34434956 Free PMC article. Review.
-
Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population.Clin Transl Radiat Oncol. 2022 Aug 6;37:78-84. doi: 10.1016/j.ctro.2022.08.003. eCollection 2022 Nov. Clin Transl Radiat Oncol. 2022. PMID: 36093341 Free PMC article.
-
A Ten-year-long Update on Radiation Proctitis Among Prostate Cancer Patients Treated With Curative External Beam Radiotherapy.In Vivo. 2021 May-Jun;35(3):1379-1391. doi: 10.21873/invivo.12390. Epub 2021 Apr 28. In Vivo. 2021. PMID: 33910815 Free PMC article. Review.
-
Risk factors for rectal bleeding in prostate cancer after radiotherapy with a validation of current rectal dose constraints.Acta Oncol. 2025 May 8;64:644-653. doi: 10.2340/1651-226X.2025.42551. Acta Oncol. 2025. PMID: 40338076 Free PMC article.
-
Imaging of surgical bed complications after prostatectomy and radiation therapy.Abdom Radiol (NY). 2025 Jun 4. doi: 10.1007/s00261-025-05027-2. Online ahead of print. Abdom Radiol (NY). 2025. PMID: 40464846 Review.
References
-
- Pinkawa M, Piroth MD, Holy R, Djukic V, Klotz J, Krenkel B, et al. Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer. Strahlentherapie und Onkologie. 2011;187(8):479–484. doi: 10.1007/s00066-011-2249-z. - DOI - PubMed
-
- Kuban DA, Levy LB, Cheung MR, Lee AK, Choi S, Frank S, et al. Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer Who dies of disease? International Journal of Radiation Oncology Biology Physics. 2011;79(5):1310–1317. doi: 10.1016/j.ijrobp.2010.01.006. - DOI - PubMed
-
- Ozyigit G, Onal C, Igdem S, Alicikus ZA, Iribas A, Akin M, et al. Treatment outcomes of prostate cancer patients with Gleason score 8–10 treated with definitive radiotherapy : TROD 09–001 multi-institutional study. Strahlentherapie und Onkologie. 2019;195(10):882–893. doi: 10.1007/s00066-019-01476-z. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical